Article metrics

Download PDFPDF

654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to January 2024

AbstractFullPdf
Nov 2023345021
Dec 20234405
Jan 20246907
Total458033